These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 18305947

  • 1. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takahashi H, Zhang Y, Morita E.
    Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947
    [Abstract] [Full Text] [Related]

  • 2. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H, Ishida-Yamamoto A, Iizuka H.
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takeo T, Kasugai C, Tanaka R, Ando T, Ogawa A, Akita Y, Watanabe D.
    J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA, Riethuisen JM, Moulaert B, DeVos C.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A, Duvernelle C, Melac M, Pauli G, Frossard N.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [Abstract] [Full Text] [Related]

  • 6. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K, Kruszewski J, Kruszewski R, Sułek K.
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [Abstract] [Full Text] [Related]

  • 7. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA, White MV, Economides A, Crisalida T, Hale M, Liao Y, Christian CD, Georges GC, Woodworth TH, Meeves SG.
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [Abstract] [Full Text] [Related]

  • 8. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
    Purohit A, N'Gom AS, Deslandes B, Pauli G, Frossard N.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W, Warrington S, Boyce M, Luria X.
    Drugs Exp Clin Res; 2002 Dec; 28(6):243-7. PubMed ID: 12776578
    [Abstract] [Full Text] [Related]

  • 10. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Kruszewski J, Kłos K, Sułek K.
    Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: suppressive effects on skin response to histamine iontophoresis.
    Morita E, Matsuo H, Zhang Y.
    J Dermatol; 2005 Jan; 32(1):58-61. PubMed ID: 15841664
    [Abstract] [Full Text] [Related]

  • 12. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
    Kamei H, Isaji A, Noda Y, Ishikawa K, Senzaki K, Yamada K, Sugiura K, Tomita Y, Nabeshima T.
    Arch Dermatol Res; 2012 May; 304(4):263-72. PubMed ID: 22130869
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D, Rihoux JP.
    Skin Pharmacol; 1988 May; 1(3):192-9. PubMed ID: 2908486
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
    Grant JA, Danielson L, Rihoux JP, DeVos C.
    Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
    Kamei H, Noda Y, Ishikawa K, Senzaki K, Muraoka I, Hasegawa Y, Hindmarch I, Nabeshima T.
    Hum Psychopharmacol; 2003 Dec; 18(8):611-8. PubMed ID: 14696020
    [Abstract] [Full Text] [Related]

  • 16. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P, Caplain H, Chaufour S, Ulliac N, Cabanis MJ, Thebault JJ.
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [Abstract] [Full Text] [Related]

  • 17. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K.
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [Abstract] [Full Text] [Related]

  • 18. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T, Stoltz M, Weir S.
    Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
    [Abstract] [Full Text] [Related]

  • 20. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
    Frossard N, Melac M, Benabdesselam O, Pauli G.
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.